chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 98.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Leukocytosis, Lung consolidation, Metabolic acidosis, Oxygen saturation decreased, Pleural effusion
Clinical narrative: presented to the ED on 9/8/21 and admitted with SOB and diarrhea. The pt was sent 9/8/2021. The patients daughter stated that the patient received both doses of the covid vaccine.    In the ED, the pt test positive for COVID-19. She was hypertensive and sat at 81% on 4LNC. She had a leukocytosis and was hyponatremic. ABG suggestive of primary respiratory alkalosis with secondary metabolic acidosis. The patients BNP was 390, CRP 9.7, ferritin 356, D-dimer 2.95. CXR showed evidence of HF with cardiomegaly with moderate R and small L pleural effusions and likely pulmonary edema. CTA demonstrated no presence of PE, only changes of CHF and moderate b/l pleural effusions and consolidation likely representing atelectasis.    Pt was admitted for management of COVID 19 pnuemonia and CHF exacerbation, and hyponatremia. She was started on Remdesivir 200mg x1 followed by 100mg daily, Decadron 6mg daily, Rocephin 1g IV daily, Azithromycin 500mg x1 followed by 250mg daily, Lopressor 25mg BID. She received 1 dose of Lasix 40mg. She was started on 4L oxygen. She tested negative for legionella and strep. Over the 6 day course of her hospitalization the pt?s oxygen levels improved and was gradually weaned off oxygen. Her COVID labs were monitored daily. Her hyponatremia resolved with improved oral intake. She was evaluated by PT/OT. She was discharged back to Residence.  Pt is to continue home medications and starting decadron for 4 more days, Mucinex 600mg,  Albuterol inhaler, Miconazole Nitrate Powder as described above.
Age: 98.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary oedema, QRS axis abnormal, Respiratory alkalosis, SARS-CoV-2 test positive, Serum ferritin increased
Clinical narrative: presented to the ED on 9/8/21 and admitted with SOB and diarrhea. The pt was sent 9/8/2021. The patients daughter stated that the patient received both doses of the covid vaccine.    In the ED, the pt test positive for COVID-19. She was hypertensive and sat at 81% on 4LNC. She had a leukocytosis and was hyponatremic. ABG suggestive of primary respiratory alkalosis with secondary metabolic acidosis. The patients BNP was 390, CRP 9.7, ferritin 356, D-dimer 2.95. CXR showed evidence of HF with cardiomegaly with moderate R and small L pleural effusions and likely pulmonary edema. CTA demonstrated no presence of PE, only changes of CHF and moderate b/l pleural effusions and consolidation likely representing atelectasis.    Pt was admitted for management of COVID 19 pnuemonia and CHF exacerbation, and hyponatremia. She was started on Remdesivir 200mg x1 followed by 100mg daily, Decadron 6mg daily, Rocephin 1g IV daily, Azithromycin 500mg x1 followed by 250mg daily, Lopressor 25mg BID. She received 1 dose of Lasix 40mg. She was started on 4L oxygen. She tested negative for legionella and strep. Over the 6 day course of her hospitalization the pt?s oxygen levels improved and was gradually weaned off oxygen. Her COVID labs were monitored daily. Her hyponatremia resolved with improved oral intake. She was evaluated by PT/OT. She was discharged back to Residence.  Pt is to continue home medications and starting decadron for 4 more days, Mucinex 600mg,  Albuterol inhaler, Miconazole Nitrate Powder as described above.
Age: 98.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Streptococcus test negative
Clinical narrative: presented to the ED on 9/8/21 and admitted with SOB and diarrhea. The pt was sent 9/8/2021. The patients daughter stated that the patient received both doses of the covid vaccine.    In the ED, the pt test positive for COVID-19. She was hypertensive and sat at 81% on 4LNC. She had a leukocytosis and was hyponatremic. ABG suggestive of primary respiratory alkalosis with secondary metabolic acidosis. The patients BNP was 390, CRP 9.7, ferritin 356, D-dimer 2.95. CXR showed evidence of HF with cardiomegaly with moderate R and small L pleural effusions and likely pulmonary edema. CTA demonstrated no presence of PE, only changes of CHF and moderate b/l pleural effusions and consolidation likely representing atelectasis.    Pt was admitted for management of COVID 19 pnuemonia and CHF exacerbation, and hyponatremia. She was started on Remdesivir 200mg x1 followed by 100mg daily, Decadron 6mg daily, Rocephin 1g IV daily, Azithromycin 500mg x1 followed by 250mg daily, Lopressor 25mg BID. She received 1 dose of Lasix 40mg. She was started on 4L oxygen. She tested negative for legionella and strep. Over the 6 day course of her hospitalization the pt?s oxygen levels improved and was gradually weaned off oxygen. Her COVID labs were monitored daily. Her hyponatremia resolved with improved oral intake. She was evaluated by PT/OT. She was discharged back to Residence.  Pt is to continue home medications and starting decadron for 4 more days, Mucinex 600mg,  Albuterol inhaler, Miconazole Nitrate Powder as described above.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Moderna vaccine (NDC--8077-0273-99, lot # 048C21A) was received on 7/16/2021 and placed under refrigerated temperature.  3 vials were transferred to Walmart store 2136 where 20 doses were administered beyond use date.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Headache
Clinical narrative: Intermittent chest pressure and headaches
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Atelectasis, Blood gases, Body temperature increased, Bronchial secretion retention
Clinical narrative: a long-term nursing home  resident, who has been fully vaccinated against COVID-19 about 7 months ago,  comes to emergency room complaining of sudden onset of temp substernal chest pain  with no associated shortness of breath, cough, fever.  His workup in the ER  showed a normal CMP.  His CBC was within normal limits excepting a hemoglobin  of 8.8 with a baseline being around 11.2.  Patient denies any epistaxis,  hemoptysis, hematemesis, melena, hematochezia, hematuria, and his stool for  occult blood was indeed negative; however, his COVID-19 screen came back as  positive.  Chest x-ray was raising possibility of infection or malignancy, so  a CT angio of the chest was done which shows no PE, but shows bilateral  ground-glass opacity, especially in the upper lobes consistent with COVID-19.   There is some bilateral mucus plugging as well and some small complex left  loculated pleural fluid, empyema versus sequelae of old hemothorax.  An ABG  was ordered and then the hospitalist service was called for admission.  Please  note, the pulmonologist is also being called for further workup.  At this  point of time, it appears prudent to have the patient admitted as an  observation to our COVID-19 unit.  I am starting the patient on some vitamin  D, vitamin C, and Mucinex.  We will await his ABG results to see if he would  benefit for any Decadron or not.  Please note, the patient's temperature was  100.1 when he came in.  His influenza swab was negative.  Because of  possibility of empyema, I might start him on Zosyn at this point of time and  have Pulmonary see him in the morning with a possible consult to IR to see if  his loculated pleural effusion even needs to be drained or treated  empirically.small left complex loculated effusion with pleural thickening , empyema vs sequela of hemothorax was suggested on CT scan report 09/10/21. He had positive  COVID 19 on admission 09/10/21 ( apparently fully vaccinated 7 months ago) . He was started  on zosyn, I discharged him on augmentin . Patient was initially on room air , and then 2 L NC , but back to room air. I started decadron and Remdesivir when he was using oxygen , but now doing well on RA.  Both cardiology and pulmonary medicine were consulted by admitting physician. Patient was evaluated by pulmonary medicine in course of hospitalization with plan for outpatient follow up . Patient does not want any surgical procedures for left pleural effusion at this time , but ok for follow up appointment with pulmonary medicine. I corresponded with case management who arranged a referral to facility with Dr.     EKG and trop on admission  did not show acute changes suggestive of ACS . Cardiology recommended medical management , patient was started on Carvedilol , Amlodipine . He also has iron deficiency anemia and started on Ferous sulphate 325 mg BID upon discharge.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Chest pain, Electrocardiogram, Empyema
Clinical narrative: a long-term nursing home  resident, who has been fully vaccinated against COVID-19 about 7 months ago,  comes to emergency room complaining of sudden onset of temp substernal chest pain  with no associated shortness of breath, cough, fever.  His workup in the ER  showed a normal CMP.  His CBC was within normal limits excepting a hemoglobin  of 8.8 with a baseline being around 11.2.  Patient denies any epistaxis,  hemoptysis, hematemesis, melena, hematochezia, hematuria, and his stool for  occult blood was indeed negative; however, his COVID-19 screen came back as  positive.  Chest x-ray was raising possibility of infection or malignancy, so  a CT angio of the chest was done which shows no PE, but shows bilateral  ground-glass opacity, especially in the upper lobes consistent with COVID-19.   There is some bilateral mucus plugging as well and some small complex left  loculated pleural fluid, empyema versus sequelae of old hemothorax.  An ABG  was ordered and then the hospitalist service was called for admission.  Please  note, the pulmonologist is also being called for further workup.  At this  point of time, it appears prudent to have the patient admitted as an  observation to our COVID-19 unit.  I am starting the patient on some vitamin  D, vitamin C, and Mucinex.  We will await his ABG results to see if he would  benefit for any Decadron or not.  Please note, the patient's temperature was  100.1 when he came in.  His influenza swab was negative.  Because of  possibility of empyema, I might start him on Zosyn at this point of time and  have Pulmonary see him in the morning with a possible consult to IR to see if  his loculated pleural effusion even needs to be drained or treated  empirically.small left complex loculated effusion with pleural thickening , empyema vs sequela of hemothorax was suggested on CT scan report 09/10/21. He had positive  COVID 19 on admission 09/10/21 ( apparently fully vaccinated 7 months ago) . He was started  on zosyn, I discharged him on augmentin . Patient was initially on room air , and then 2 L NC , but back to room air. I started decadron and Remdesivir when he was using oxygen , but now doing well on RA.  Both cardiology and pulmonary medicine were consulted by admitting physician. Patient was evaluated by pulmonary medicine in course of hospitalization with plan for outpatient follow up . Patient does not want any surgical procedures for left pleural effusion at this time , but ok for follow up appointment with pulmonary medicine. I corresponded with case management who arranged a referral to facility with Dr.     EKG and trop on admission  did not show acute changes suggestive of ACS . Cardiology recommended medical management , patient was started on Carvedilol , Amlodipine . He also has iron deficiency anemia and started on Ferous sulphate 325 mg BID upon discharge.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Full blood count abnormal, Haemoglobin decreased, Haemothorax, Influenza virus test negative, Iron deficiency anaemia
Clinical narrative: a long-term nursing home  resident, who has been fully vaccinated against COVID-19 about 7 months ago,  comes to emergency room complaining of sudden onset of temp substernal chest pain  with no associated shortness of breath, cough, fever.  His workup in the ER  showed a normal CMP.  His CBC was within normal limits excepting a hemoglobin  of 8.8 with a baseline being around 11.2.  Patient denies any epistaxis,  hemoptysis, hematemesis, melena, hematochezia, hematuria, and his stool for  occult blood was indeed negative; however, his COVID-19 screen came back as  positive.  Chest x-ray was raising possibility of infection or malignancy, so  a CT angio of the chest was done which shows no PE, but shows bilateral  ground-glass opacity, especially in the upper lobes consistent with COVID-19.   There is some bilateral mucus plugging as well and some small complex left  loculated pleural fluid, empyema versus sequelae of old hemothorax.  An ABG  was ordered and then the hospitalist service was called for admission.  Please  note, the pulmonologist is also being called for further workup.  At this  point of time, it appears prudent to have the patient admitted as an  observation to our COVID-19 unit.  I am starting the patient on some vitamin  D, vitamin C, and Mucinex.  We will await his ABG results to see if he would  benefit for any Decadron or not.  Please note, the patient's temperature was  100.1 when he came in.  His influenza swab was negative.  Because of  possibility of empyema, I might start him on Zosyn at this point of time and  have Pulmonary see him in the morning with a possible consult to IR to see if  his loculated pleural effusion even needs to be drained or treated  empirically.small left complex loculated effusion with pleural thickening , empyema vs sequela of hemothorax was suggested on CT scan report 09/10/21. He had positive  COVID 19 on admission 09/10/21 ( apparently fully vaccinated 7 months ago) . He was started  on zosyn, I discharged him on augmentin . Patient was initially on room air , and then 2 L NC , but back to room air. I started decadron and Remdesivir when he was using oxygen , but now doing well on RA.  Both cardiology and pulmonary medicine were consulted by admitting physician. Patient was evaluated by pulmonary medicine in course of hospitalization with plan for outpatient follow up . Patient does not want any surgical procedures for left pleural effusion at this time , but ok for follow up appointment with pulmonary medicine. I corresponded with case management who arranged a referral to facility with Dr.     EKG and trop on admission  did not show acute changes suggestive of ACS . Cardiology recommended medical management , patient was started on Carvedilol , Amlodipine . He also has iron deficiency anemia and started on Ferous sulphate 325 mg BID upon discharge.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lung consolidation, Lung opacity, Metabolic function test, Occult blood negative, Pleural effusion
Clinical narrative: a long-term nursing home  resident, who has been fully vaccinated against COVID-19 about 7 months ago,  comes to emergency room complaining of sudden onset of temp substernal chest pain  with no associated shortness of breath, cough, fever.  His workup in the ER  showed a normal CMP.  His CBC was within normal limits excepting a hemoglobin  of 8.8 with a baseline being around 11.2.  Patient denies any epistaxis,  hemoptysis, hematemesis, melena, hematochezia, hematuria, and his stool for  occult blood was indeed negative; however, his COVID-19 screen came back as  positive.  Chest x-ray was raising possibility of infection or malignancy, so  a CT angio of the chest was done which shows no PE, but shows bilateral  ground-glass opacity, especially in the upper lobes consistent with COVID-19.   There is some bilateral mucus plugging as well and some small complex left  loculated pleural fluid, empyema versus sequelae of old hemothorax.  An ABG  was ordered and then the hospitalist service was called for admission.  Please  note, the pulmonologist is also being called for further workup.  At this  point of time, it appears prudent to have the patient admitted as an  observation to our COVID-19 unit.  I am starting the patient on some vitamin  D, vitamin C, and Mucinex.  We will await his ABG results to see if he would  benefit for any Decadron or not.  Please note, the patient's temperature was  100.1 when he came in.  His influenza swab was negative.  Because of  possibility of empyema, I might start him on Zosyn at this point of time and  have Pulmonary see him in the morning with a possible consult to IR to see if  his loculated pleural effusion even needs to be drained or treated  empirically.small left complex loculated effusion with pleural thickening , empyema vs sequela of hemothorax was suggested on CT scan report 09/10/21. He had positive  COVID 19 on admission 09/10/21 ( apparently fully vaccinated 7 months ago) . He was started  on zosyn, I discharged him on augmentin . Patient was initially on room air , and then 2 L NC , but back to room air. I started decadron and Remdesivir when he was using oxygen , but now doing well on RA.  Both cardiology and pulmonary medicine were consulted by admitting physician. Patient was evaluated by pulmonary medicine in course of hospitalization with plan for outpatient follow up . Patient does not want any surgical procedures for left pleural effusion at this time , but ok for follow up appointment with pulmonary medicine. I corresponded with case management who arranged a referral to facility with Dr.     EKG and trop on admission  did not show acute changes suggestive of ACS . Cardiology recommended medical management , patient was started on Carvedilol , Amlodipine . He also has iron deficiency anemia and started on Ferous sulphate 325 mg BID upon discharge.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pleural thickening, Pneumonia, SARS-CoV-2 test positive, Troponin
Clinical narrative: a long-term nursing home  resident, who has been fully vaccinated against COVID-19 about 7 months ago,  comes to emergency room complaining of sudden onset of temp substernal chest pain  with no associated shortness of breath, cough, fever.  His workup in the ER  showed a normal CMP.  His CBC was within normal limits excepting a hemoglobin  of 8.8 with a baseline being around 11.2.  Patient denies any epistaxis,  hemoptysis, hematemesis, melena, hematochezia, hematuria, and his stool for  occult blood was indeed negative; however, his COVID-19 screen came back as  positive.  Chest x-ray was raising possibility of infection or malignancy, so  a CT angio of the chest was done which shows no PE, but shows bilateral  ground-glass opacity, especially in the upper lobes consistent with COVID-19.   There is some bilateral mucus plugging as well and some small complex left  loculated pleural fluid, empyema versus sequelae of old hemothorax.  An ABG  was ordered and then the hospitalist service was called for admission.  Please  note, the pulmonologist is also being called for further workup.  At this  point of time, it appears prudent to have the patient admitted as an  observation to our COVID-19 unit.  I am starting the patient on some vitamin  D, vitamin C, and Mucinex.  We will await his ABG results to see if he would  benefit for any Decadron or not.  Please note, the patient's temperature was  100.1 when he came in.  His influenza swab was negative.  Because of  possibility of empyema, I might start him on Zosyn at this point of time and  have Pulmonary see him in the morning with a possible consult to IR to see if  his loculated pleural effusion even needs to be drained or treated  empirically.small left complex loculated effusion with pleural thickening , empyema vs sequela of hemothorax was suggested on CT scan report 09/10/21. He had positive  COVID 19 on admission 09/10/21 ( apparently fully vaccinated 7 months ago) . He was started  on zosyn, I discharged him on augmentin . Patient was initially on room air , and then 2 L NC , but back to room air. I started decadron and Remdesivir when he was using oxygen , but now doing well on RA.  Both cardiology and pulmonary medicine were consulted by admitting physician. Patient was evaluated by pulmonary medicine in course of hospitalization with plan for outpatient follow up . Patient does not want any surgical procedures for left pleural effusion at this time , but ok for follow up appointment with pulmonary medicine. I corresponded with case management who arranged a referral to facility with Dr.     EKG and trop on admission  did not show acute changes suggestive of ACS . Cardiology recommended medical management , patient was started on Carvedilol , Amlodipine . He also has iron deficiency anemia and started on Ferous sulphate 325 mg BID upon discharge.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye swelling, Lip swelling, Rash, Swelling face
Clinical narrative: My skin turned red. The rash spread all over my body and there were bumps all over my skin. There was swelling around my lips, eyes, and nose. I took Benadryl. Then I went to the doctor. I was diagnosed with urticaria hives. I was given a prescription of Cetirizine.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: My skin turned red. The rash spread all over my body and there were bumps all over my skin. There was swelling around my lips, eyes, and nose. I took Benadryl. Then I went to the doctor. I was diagnosed with urticaria hives. I was given a prescription of Cetirizine.
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccinated with expired vaccine by 09/14/2021. No adverse reactions noted.
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccinated with expired vaccine of 14 days. No adverse reactions noted.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Headache
Clinical narrative: About 10 minutes post vaccination, patient started experiencing labored breathing, headache and slight chest pain.  Mother of patient also stated patient has history of anxiety.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Moderna vaccine (NDC--8077-0273-99, lot # 048C21A) was received at a store on 7/16/2021 and placed under refrigerated temperature. 3 vials were transferred to another store where 20 doses were administered beyond use date.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site urticaria, Urticaria
Clinical narrative: Hives started at the vaccine injection site then wide spread over entire body
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Herpes zoster, Injection site pain, Pain
Clinical narrative: Extreme joint pain around injection site and entire left side of my body. Shingles  along my right side torso
Age: 69.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Developed 3-4" diameter very hot red marking approximately 3" below injection site that persisted for several days despite use of hydrocortisone ointment as treatment. Almost gone at 6 days post injection.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Arrived to ER on 9/13/2021. Patient is an 81-year-old female with advanced dementia, diabetes,  hypertension, tested positive for COVID on 09/08/2021.  Was vaccinated  approximately 7 months ago with Pfizer.  Has not been eating.  Has episodes of  desaturation below 90% on room air.  Patient unable to provide any history  whatsoever. Admitted to hospital on 9/13/21. She started on decadron, keep oxygen above 90%. I covered her with abx due to possible superimposed bacterial GNR PNA. She was tested positive for COVID on 09/08/2021. She was vaccinated approximately 7 months ago with Pfizer. Was started her on remdesivir 9/14; started on doxycycline and ceftriaxone. CTA confirmed Covid-19 PNA and possible superimposed RLL PNA GNR; no signs of PNA. Pt developed acute hypoxic respiratory failure with increasing oxygen requirement on 9/15. She is now on HFNC 60 liters. Niece is aware of deterioration. Ct with supportive measures.  Due to worsening of respiratory status. Talked with POA the niece and patient placed on comfort on 9/18. She was on IV prn morphine and IV ativan prn.  She passed away on 9/19/21 01:02AM
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death, Decreased appetite, General physical health deterioration, Interstitial lung disease, Lung opacity
Clinical narrative: Arrived to ER on 9/13/2021. Patient is an 81-year-old female with advanced dementia, diabetes,  hypertension, tested positive for COVID on 09/08/2021.  Was vaccinated  approximately 7 months ago with Pfizer.  Has not been eating.  Has episodes of  desaturation below 90% on room air.  Patient unable to provide any history  whatsoever. Admitted to hospital on 9/13/21. She started on decadron, keep oxygen above 90%. I covered her with abx due to possible superimposed bacterial GNR PNA. She was tested positive for COVID on 09/08/2021. She was vaccinated approximately 7 months ago with Pfizer. Was started her on remdesivir 9/14; started on doxycycline and ceftriaxone. CTA confirmed Covid-19 PNA and possible superimposed RLL PNA GNR; no signs of PNA. Pt developed acute hypoxic respiratory failure with increasing oxygen requirement on 9/15. She is now on HFNC 60 liters. Niece is aware of deterioration. Ct with supportive measures.  Due to worsening of respiratory status. Talked with POA the niece and patient placed on comfort on 9/18. She was on IV prn morphine and IV ativan prn.  She passed away on 9/19/21 01:02AM
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased, SARS-CoV-2 test positive, Ultrasound scan normal
Clinical narrative: Arrived to ER on 9/13/2021. Patient is an 81-year-old female with advanced dementia, diabetes,  hypertension, tested positive for COVID on 09/08/2021.  Was vaccinated  approximately 7 months ago with Pfizer.  Has not been eating.  Has episodes of  desaturation below 90% on room air.  Patient unable to provide any history  whatsoever. Admitted to hospital on 9/13/21. She started on decadron, keep oxygen above 90%. I covered her with abx due to possible superimposed bacterial GNR PNA. She was tested positive for COVID on 09/08/2021. She was vaccinated approximately 7 months ago with Pfizer. Was started her on remdesivir 9/14; started on doxycycline and ceftriaxone. CTA confirmed Covid-19 PNA and possible superimposed RLL PNA GNR; no signs of PNA. Pt developed acute hypoxic respiratory failure with increasing oxygen requirement on 9/15. She is now on HFNC 60 liters. Niece is aware of deterioration. Ct with supportive measures.  Due to worsening of respiratory status. Talked with POA the niece and patient placed on comfort on 9/18. She was on IV prn morphine and IV ativan prn.  She passed away on 9/19/21 01:02AM
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity, Pyrexia
Clinical narrative: Sore arm, fever, swollen lymph glands under arm, shoulder and neck
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccinated with expired vaccine by 09/14/2021. No adverse reactions noted.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Rash, Rash pruritic
Clinical narrative: Itching and burning rash on both thighs. Stared the day after administration (8-28-21) and continued for 2-3 days after.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Acute respiratory failure, Atelectasis, COVID-19, Chest X-ray abnormal
Clinical narrative: He comes to the emergency room complaining of 2-3 days of right upper  quadrant abdominal pain with nausea, vomiting, diarrhea, cough, body aches.   He said he was immunized with COVID-19 in January and February of this year.   He lives with his wife and children, none of whom are sick.  He came to  emergency room with these complaints.  He tested positive for COVID-19.  Also,  his urinalysis was abnormal showing esterase 2+ and WBC 6-10.  CT abdomen and  pelvis is raising the possibility of acute cholecystitis for which the  surgeon was called and will see the patient in the morning.  Patient was  saturating anywhere between 92% to 94% at rest, but when we did the ABG, his  pO2 was only 66.% on room air.  So, the patient was also started on Decadron  and remdesivir.  For his UTI and his COVID-19 status, he is already started on  Zosyn. Admitted on 9/13/2021. Urine culture 09/13/21 E Coli . He had acute hypoxemic respiratory failure secondary to COVID 19 viral and suspected secondary bacteria pneumonia . Was on  decadron , remdesivir , supportive oxygenation , CXR showed right basilar subsegmental atelectasis. Upon discharge , patient was not using oxygen. Discharged on 9/18/21
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cholecystitis acute, Computerised tomogram abdomen abnormal, Cough, Culture urine positive, Diarrhoea
Clinical narrative: He comes to the emergency room complaining of 2-3 days of right upper  quadrant abdominal pain with nausea, vomiting, diarrhea, cough, body aches.   He said he was immunized with COVID-19 in January and February of this year.   He lives with his wife and children, none of whom are sick.  He came to  emergency room with these complaints.  He tested positive for COVID-19.  Also,  his urinalysis was abnormal showing esterase 2+ and WBC 6-10.  CT abdomen and  pelvis is raising the possibility of acute cholecystitis for which the  surgeon was called and will see the patient in the morning.  Patient was  saturating anywhere between 92% to 94% at rest, but when we did the ABG, his  pO2 was only 66.% on room air.  So, the patient was also started on Decadron  and remdesivir.  For his UTI and his COVID-19 status, he is already started on  Zosyn. Admitted on 9/13/2021. Urine culture 09/13/21 E Coli . He had acute hypoxemic respiratory failure secondary to COVID 19 viral and suspected secondary bacteria pneumonia . Was on  decadron , remdesivir , supportive oxygenation , CXR showed right basilar subsegmental atelectasis. Upon discharge , patient was not using oxygen. Discharged on 9/18/21
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Escherichia infection, Hypopnoea, Nausea, PO2 decreased, Pain
Clinical narrative: He comes to the emergency room complaining of 2-3 days of right upper  quadrant abdominal pain with nausea, vomiting, diarrhea, cough, body aches.   He said he was immunized with COVID-19 in January and February of this year.   He lives with his wife and children, none of whom are sick.  He came to  emergency room with these complaints.  He tested positive for COVID-19.  Also,  his urinalysis was abnormal showing esterase 2+ and WBC 6-10.  CT abdomen and  pelvis is raising the possibility of acute cholecystitis for which the  surgeon was called and will see the patient in the morning.  Patient was  saturating anywhere between 92% to 94% at rest, but when we did the ABG, his  pO2 was only 66.% on room air.  So, the patient was also started on Decadron  and remdesivir.  For his UTI and his COVID-19 status, he is already started on  Zosyn. Admitted on 9/13/2021. Urine culture 09/13/21 E Coli . He had acute hypoxemic respiratory failure secondary to COVID 19 viral and suspected secondary bacteria pneumonia . Was on  decadron , remdesivir , supportive oxygenation , CXR showed right basilar subsegmental atelectasis. Upon discharge , patient was not using oxygen. Discharged on 9/18/21
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pneumonia bacterial, SARS-CoV-2 test positive, Urinary tract infection, Urine analysis abnormal, Vomiting
Clinical narrative: He comes to the emergency room complaining of 2-3 days of right upper  quadrant abdominal pain with nausea, vomiting, diarrhea, cough, body aches.   He said he was immunized with COVID-19 in January and February of this year.   He lives with his wife and children, none of whom are sick.  He came to  emergency room with these complaints.  He tested positive for COVID-19.  Also,  his urinalysis was abnormal showing esterase 2+ and WBC 6-10.  CT abdomen and  pelvis is raising the possibility of acute cholecystitis for which the  surgeon was called and will see the patient in the morning.  Patient was  saturating anywhere between 92% to 94% at rest, but when we did the ABG, his  pO2 was only 66.% on room air.  So, the patient was also started on Decadron  and remdesivir.  For his UTI and his COVID-19 status, he is already started on  Zosyn. Admitted on 9/13/2021. Urine culture 09/13/21 E Coli . He had acute hypoxemic respiratory failure secondary to COVID 19 viral and suspected secondary bacteria pneumonia . Was on  decadron , remdesivir , supportive oxygenation , CXR showed right basilar subsegmental atelectasis. Upon discharge , patient was not using oxygen. Discharged on 9/18/21
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: White blood cells urine positive
Clinical narrative: He comes to the emergency room complaining of 2-3 days of right upper  quadrant abdominal pain with nausea, vomiting, diarrhea, cough, body aches.   He said he was immunized with COVID-19 in January and February of this year.   He lives with his wife and children, none of whom are sick.  He came to  emergency room with these complaints.  He tested positive for COVID-19.  Also,  his urinalysis was abnormal showing esterase 2+ and WBC 6-10.  CT abdomen and  pelvis is raising the possibility of acute cholecystitis for which the  surgeon was called and will see the patient in the morning.  Patient was  saturating anywhere between 92% to 94% at rest, but when we did the ABG, his  pO2 was only 66.% on room air.  So, the patient was also started on Decadron  and remdesivir.  For his UTI and his COVID-19 status, he is already started on  Zosyn. Admitted on 9/13/2021. Urine culture 09/13/21 E Coli . He had acute hypoxemic respiratory failure secondary to COVID 19 viral and suspected secondary bacteria pneumonia . Was on  decadron , remdesivir , supportive oxygenation , CXR showed right basilar subsegmental atelectasis. Upon discharge , patient was not using oxygen. Discharged on 9/18/21
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray normal, Chest pain, Dyspnoea, Electrocardiogram abnormal, Pericarditis
Clinical narrative: I believe I developed pericarditis from the second shot. Got COVID-19 in Feb 2020 and got my second shot May 5th, 2021 and within three weeks I had persistent and inexplicable chest pain and shortness of breath that sent me to the ER where they discovered an abnormality in my EKG. The doctor's diagnosis was pericarditis likely due to some kind of viral infection. No other cardiovascular issues, risks, or prior events. It went away shortly after but has come back this week. I don't have healthcare here in NY until Oct 1st 2021 so as soon as I can get in to see a doctor I will seek further treatment.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Viral infection
Clinical narrative: I believe I developed pericarditis from the second shot. Got COVID-19 in Feb 2020 and got my second shot May 5th, 2021 and within three weeks I had persistent and inexplicable chest pain and shortness of breath that sent me to the ER where they discovered an abnormality in my EKG. The doctor's diagnosis was pericarditis likely due to some kind of viral infection. No other cardiovascular issues, risks, or prior events. It went away shortly after but has come back this week. I don't have healthcare here in NY until Oct 1st 2021 so as soon as I can get in to see a doctor I will seek further treatment.
Age: 17.0
Sex: M
Vaccine: COVID19, HEP, HEPA, HPV9, IPV, MMR, MNQ, TDAP, VARCEL
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccinated with expired vaccine by 10 days. No adverse reaction
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Burning sensation, Electric shock sensation, Hypoaesthesia, Immediate post-injection reaction
Clinical narrative: Immediately upon vaccine injection I felt intense burning and shooting pain where it was injected.  It was painful, almost like an electrical current, and I could feel the solution entering my arm and surrounding area.  I told the pharmacists this injection was painful and she said it was normal.  The injection was located at the lower front side of my upper arm and I do not believe the needle was inserted anywhere near the correct location, which I was told should be in the middle of your deltoid muscle.  Since the minute the vaccine was injected, my right arm has been in severe pain.    I went back to the pharmacy 11 days after injection to ask about the debilitating pain I have been experiencing since the vaccine and was told it was normal and that it should clear up within 2 weeks.  One month after the vaccine I went back to the same pharmacy to ask again if the pain I have been experiencing should still be persisting 30 days after injection.  I was again told that it is normal.   Two months later I was back at the pharmacy asking about the pain and told AGAIN that it will go away.  Every movement my right arm makes results in shooting pain at the injection site on my arm and down thru my arm to my right hand.  I am unable to perform normal daily tasks, I cannot sleep on my right side or stomach, I'm not able to do perform any exercises with my right arm or hold heavy objects.  It was only after I went to see my Doctor on 8/30/21 that I was officially diagnosed with an injury due to the vaccine.  To date (9/19/21), my right arm has increasing gotten worse.  Three months later and the mobility in my arm is less than it has ever been and extremely painful.  I feel a constant burning sensation and numbness throughout my arm.  I have also experienced disruption in my menstrual cycle since the vaccine.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Injected limb mobility decreased, Injection site pain, Injury, Instillation site paraesthesia
Clinical narrative: Immediately upon vaccine injection I felt intense burning and shooting pain where it was injected.  It was painful, almost like an electrical current, and I could feel the solution entering my arm and surrounding area.  I told the pharmacists this injection was painful and she said it was normal.  The injection was located at the lower front side of my upper arm and I do not believe the needle was inserted anywhere near the correct location, which I was told should be in the middle of your deltoid muscle.  Since the minute the vaccine was injected, my right arm has been in severe pain.    I went back to the pharmacy 11 days after injection to ask about the debilitating pain I have been experiencing since the vaccine and was told it was normal and that it should clear up within 2 weeks.  One month after the vaccine I went back to the same pharmacy to ask again if the pain I have been experiencing should still be persisting 30 days after injection.  I was again told that it is normal.   Two months later I was back at the pharmacy asking about the pain and told AGAIN that it will go away.  Every movement my right arm makes results in shooting pain at the injection site on my arm and down thru my arm to my right hand.  I am unable to perform normal daily tasks, I cannot sleep on my right side or stomach, I'm not able to do perform any exercises with my right arm or hold heavy objects.  It was only after I went to see my Doctor on 8/30/21 that I was officially diagnosed with an injury due to the vaccine.  To date (9/19/21), my right arm has increasing gotten worse.  Three months later and the mobility in my arm is less than it has ever been and extremely painful.  I feel a constant burning sensation and numbness throughout my arm.  I have also experienced disruption in my menstrual cycle since the vaccine.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Menstrual disorder, Pain, Pain in extremity, Sleep disorder
Clinical narrative: Immediately upon vaccine injection I felt intense burning and shooting pain where it was injected.  It was painful, almost like an electrical current, and I could feel the solution entering my arm and surrounding area.  I told the pharmacists this injection was painful and she said it was normal.  The injection was located at the lower front side of my upper arm and I do not believe the needle was inserted anywhere near the correct location, which I was told should be in the middle of your deltoid muscle.  Since the minute the vaccine was injected, my right arm has been in severe pain.    I went back to the pharmacy 11 days after injection to ask about the debilitating pain I have been experiencing since the vaccine and was told it was normal and that it should clear up within 2 weeks.  One month after the vaccine I went back to the same pharmacy to ask again if the pain I have been experiencing should still be persisting 30 days after injection.  I was again told that it is normal.   Two months later I was back at the pharmacy asking about the pain and told AGAIN that it will go away.  Every movement my right arm makes results in shooting pain at the injection site on my arm and down thru my arm to my right hand.  I am unable to perform normal daily tasks, I cannot sleep on my right side or stomach, I'm not able to do perform any exercises with my right arm or hold heavy objects.  It was only after I went to see my Doctor on 8/30/21 that I was officially diagnosed with an injury due to the vaccine.  To date (9/19/21), my right arm has increasing gotten worse.  Three months later and the mobility in my arm is less than it has ever been and extremely painful.  I feel a constant burning sensation and numbness throughout my arm.  I have also experienced disruption in my menstrual cycle since the vaccine.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Weight bearing difficulty
Clinical narrative: Immediately upon vaccine injection I felt intense burning and shooting pain where it was injected.  It was painful, almost like an electrical current, and I could feel the solution entering my arm and surrounding area.  I told the pharmacists this injection was painful and she said it was normal.  The injection was located at the lower front side of my upper arm and I do not believe the needle was inserted anywhere near the correct location, which I was told should be in the middle of your deltoid muscle.  Since the minute the vaccine was injected, my right arm has been in severe pain.    I went back to the pharmacy 11 days after injection to ask about the debilitating pain I have been experiencing since the vaccine and was told it was normal and that it should clear up within 2 weeks.  One month after the vaccine I went back to the same pharmacy to ask again if the pain I have been experiencing should still be persisting 30 days after injection.  I was again told that it is normal.   Two months later I was back at the pharmacy asking about the pain and told AGAIN that it will go away.  Every movement my right arm makes results in shooting pain at the injection site on my arm and down thru my arm to my right hand.  I am unable to perform normal daily tasks, I cannot sleep on my right side or stomach, I'm not able to do perform any exercises with my right arm or hold heavy objects.  It was only after I went to see my Doctor on 8/30/21 that I was officially diagnosed with an injury due to the vaccine.  To date (9/19/21), my right arm has increasing gotten worse.  Three months later and the mobility in my arm is less than it has ever been and extremely painful.  I feel a constant burning sensation and numbness throughout my arm.  I have also experienced disruption in my menstrual cycle since the vaccine.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Blood creatine phosphokinase increased, Blood creatinine increased, COVID-19, Chest X-ray
Clinical narrative: This is a 22-year-old gentleman who is a student of a local  college here who has been immunized against COVID-19 in August.  Then about 10  days ago, he had to have a COVID-19 test done because he was exposed to  somebody on his football team who had COVID-19 and he did test positive.  He  just came out of quarantine yesterday and had a long workout session for his  football team, but was not drinking enough fluid, started to have abdominal cramps  and then arms and leg cramps and therefore came to the emergency room where  his creatinine was found to be 1.6, without a baseline in our system.  Also,  his CPK was 791, which after a L of fluid actually went to 832.  The patient  says he feels a whole lot better right now and his cramps are almost resolved.   We will give him a couple more L of fluids and recheck his CPK and BMP in a  few hours and then make a decision whether the patient can be discharged from  the ER or be admitted for his possible AKI and elevated CPK.  He also has a  slight white count of 11.43, but he is denying any chest pain, shortness of  breath or cough, fever or chills. No urinary s/s..  Mild leukocytosis with a recent COVID-19 infection.  Checking chest x-ray  and urinalysis.  Patient denies any fever, chills, or cough or any urinary  symptoms.  No diarrhea either.  Given fluids and discharged on 9/17/21
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Leukocytosis, Muscle spasms, SARS-CoV-2 test positive, Urine analysis, White blood cell count increased
Clinical narrative: This is a 22-year-old gentleman who is a student of a local  college here who has been immunized against COVID-19 in August.  Then about 10  days ago, he had to have a COVID-19 test done because he was exposed to  somebody on his football team who had COVID-19 and he did test positive.  He  just came out of quarantine yesterday and had a long workout session for his  football team, but was not drinking enough fluid, started to have abdominal cramps  and then arms and leg cramps and therefore came to the emergency room where  his creatinine was found to be 1.6, without a baseline in our system.  Also,  his CPK was 791, which after a L of fluid actually went to 832.  The patient  says he feels a whole lot better right now and his cramps are almost resolved.   We will give him a couple more L of fluids and recheck his CPK and BMP in a  few hours and then make a decision whether the patient can be discharged from  the ER or be admitted for his possible AKI and elevated CPK.  He also has a  slight white count of 11.43, but he is denying any chest pain, shortness of  breath or cough, fever or chills. No urinary s/s..  Mild leukocytosis with a recent COVID-19 infection.  Checking chest x-ray  and urinalysis.  Patient denies any fever, chills, or cough or any urinary  symptoms.  No diarrhea either.  Given fluids and discharged on 9/17/21
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Interchange of vaccine products
Clinical narrative: The patient received Pfizer on 01/16/21 and 02/06/21, Moderna on 06/09/21 and Janssen on 09/09/21
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Rash, Rash pruritic, Vaccine positive rechallenge
Clinical narrative: Burning and itching rash on both thighs. Started 2 days after vaccination (today-9-19-21) I still have it, the same reaction happened with the first dose.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Moderna vaccine (NDC--80777-0273-99, lot # 048C21A) was received on 7/16/2021 and placed under refrigerated temperature.  3 vials were transferred to store where 20 doses were administered beyond use date.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Hypersensitivity, Rash, Skin discolouration, Urticaria
Clinical narrative: I?ve been breaking out in hives every 2-3 days. The original rash is still here a month later but now it?s gray.
Age: 74.0
Sex: M
Vaccine: TDAP
Symptoms: Arthralgia, Back pain, Pain in extremity
Clinical narrative: Severe pain in both hips, upper right thigh, and lower back; virtually constant. Treatment was the use of OTC Tylenol Arthritis Extended Release 650mgs, (2) three times a day. After approx 12 weeks pains abated except for lower back pain which is consistent with the chronic pain I experience. There are infrequent but occasional recurrences of acute hip oain.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Insomnia, Limb discomfort, Musculoskeletal discomfort
Clinical narrative: a horrible headache, which lasted for about 36 hours and sleeplessness  legs felt like they weighed 200 lbs and felt like i was carrying weight on my back..  e
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccinated with expired vaccine by 09/14/2021. No adverse reactions noted.